2017 ADVISORY BOARD INCLUDES:

 

Puja Sapra

Puja Sapra
Executive Director

Pfizer

Frank Walsh

Frank Walsh
Chief Executive Officer

Ossianix

Christian Klein

Christian Klein
Head Oncology Programs

Roche

Dario Neri

Dario Neri
Founder, Professor of Chemistry and Applied Bios

Philogen, Swiss Federal Institute of Technology Zurich

Janice Reichert

Janice Reichert
Executive Director

The Antibody Society

Scott Dylla

Scott Dylla
Vice President of Research & Development Chief Scientific Officer

Abbvie Stemcentrx

Mark Chiu

Mark Chiu
Associate Director, Multispecific Biologics Engineering

Jannssen

Ulf Grawunder

Ulf Grawunder
Chief Executive Officer & Founder

NBE Therapeutics

CLICK HERE TO SEE THE FULL ADVISORY BOARD

WHAT IS THE WORLD IMMUNOTHERAPY CONGRESS?

STRATEGIC CONFERENCE

Immunotherapy conference speakers

The congress brings together experts to discuss immune checkpoint inhibitors and cell therapy with a focus on some exciting customisations such as CAR-T and Oncolytic Viral Immunotherapy. Join us for keynotes, presentations and roundtables. 

READ MORE

SOLUTION PROVIDER EXHIBITION

Exhibit at the world immunotherapy congress

A great opportunity to debut new solutions, improve your brand awareness, meet new prospective clients and maintain existing relationships. 
 Email Derek.Cavanagh@terrapinn.com  for sponsorship information.

READ MORE

EXCELLENT NETWORKING

Network at World Immunotherapy congress

We understand the importance of networking. Meet over 400 of your peers in one room and take advantage of the multiple extended networking breaks, co-located with European Antibody Congress, World Biosimilar Congress and the HPAPI World Congress.

READ MORE

80+ Speakers

500+ meetings

50+ Exhibitors

3   Days

PIONEERS THAT JOINED US FOR 2016 INCLUDE:  

 

  • Dr Renier Brentjens at World Immunotherapy Congress
    Dr Renier Brentjens
    Director, Cellular Therapeutics
    Memorial Sloan-Kettering Cancer Center
  • Dr Berthold Boedeker at World Immunotherapy Congress
    Dr Berthold Boedeker
    Chief Scientist
    Bayer Ag
  • Dr Patricia Gräf at World Immunotherapy Congress
    Dr Patricia Gräf
    Associate Scientist Immunology R&D
    Juno Therapeutics
  • Dr Patrick Burke at World Immunotherapy Congress
    Dr Patrick Burke
    Associate Director
    Seattle Genetics, Inc.
  • Dr Thomas Sandal at World Immunotherapy Congress
    Dr Thomas Sandal
    VP R&D
    Crescendo Biologics Ltd
  • Dr Christian Klein at World Immunotherapy Congress
    Dr Christian Klein
    Head Oncology Programs
    Roche Pharmaceutical Research and Early Development
  • Dr Olivier Heudi at World Immunotherapy Congress
    Dr Olivier Heudi
    Research Investigator
    Novartis Ag
  • Dr Yasmina Abdiche at World Immunotherapy Congress
    Dr Yasmina Abdiche
    CSO
    Wasatch Microfluidics
  • Dr Robert Wilkinson at World Immunotherapy Congress
    Dr Robert Wilkinson
    Director of Oncology Research
    MedImmune
  • Dr Jiri Kovarik at World Immunotherapy Congress
    Dr Jiri Kovarik
    Research Investigator
    N.I.B.R.
  • Mr Etienne Drouet at World Immunotherapy Congress
    Mr Etienne Drouet
    Vice President of Strategic Development
    Synteract H.C.R. Iberica Sl
  • Dr Marc Damelin at World Immunotherapy Congress
    Dr Marc Damelin
    Associate Director
    Pfizer Worldwide Research & Development
  • Dr Ulf Grawunder at World Immunotherapy Congress
    Dr Ulf Grawunder
    Chief Executive Officer & Founder
    NBE Therapeutics
  • Dr Seth Ettenberg at World Immunotherapy Congress
    Dr Seth Ettenberg
    Chief Scientific Officer
    Unum Therapeutics Inc.
  • Dr Sonia Quaratino at World Immunotherapy Congress
    Dr Sonia Quaratino
    Global Clinical Program Leader
    Novartis Institutes For BioMedical Research

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PARTNER WITH THE WORLD IMMUNOTHERAPY CONGRESS 

 

Forge new partnerships

Generate new leads

Build your brand presence

 

DOWNLOAD PROSPECTUS

TESTIMONIALS

 

"It was a great congress with interesting speakers and cutting edge research. There was ample time for networking and a good atmosphere to promote this. Time keeping was good. Food and venue was excellent. I will be back next year!"

Head of Protein Production and Characterization   MRC Technology

"Very good speakers and interesting content."

 Global Clinical Program Leader

Novartis Institutes For BioMedical Research

 

"Interesting range and depth of talks."

 Preclinical Scientist

Cancer Research UK

 

 

"Excellent organization, interesting talks, good network opportunities."

Institute of Cell Culture and Immunotherapy

University of Stuttgart    

BOOK NOW

WHO ATTENDS

Lonza.  Adaptimmune.  Boehringer Ingelheim.  AstraZeneca. Juno Therapeutics.  Novartis pHarma AG.  Amal Therapeutics.  Cellectis.  Cancer Research UK.  Scancell Ltd.  MedImmune.  Mologen AG.  Axenis.  Immatics Biotechnologies GmbH.  MaxCyte, Inc.  Experimential Cancer Medicine Centres Network.  BioCanRx. Icon Plc.  Philips Research.  Actelion Pharmaceuticals Ltd.  University Hospital Basel.  Roche Pharmaceutical Research and Early Development.  Immunocore.

 

DOWNLOAD PROSPECTUS 

                                                        GET INVOLVED FOR 2017

immunotherapy 2016 brochure

In bringing together the key players from the immunotherapy community, this event provides an unrivalled opportunity to expose and address the current challenges facing the industry. 

Download the sponsorship prospectus to find out how this event can meet your sales and marketing objectives.

 

SPONSOR NOW